Biological
gut microbiota analysis
gut microbiota analysis is a biological therapy with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph early_phase_1
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
Early Phase 1First-in-human
1(100.0%)
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Recruiting1
Enrolling by invitation1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 11 (100.0%)
Trials by Status
recruiting133%
enrolling_by_invitation133%
completed133%
Recent Activity
1 active trials
Showing 3 of 3
enrolling_by_invitationearly_phase_1
Program Protocol for a Population That Works in Conditions of Hypobaric Hypoxia
NCT07624409
recruiting
MelPRO-0322 (CRISTINA Trial) [miCrobiome pRedIctS aPD1 effecTivnes In melaNoma pAtietns]
NCT06299878
completed
Gut Microbiota Analysis in IAI Patients With Sepsis-associated Liver Dysfunction
NCT05628493
Clinical Trials (3)
Showing 3 of 3 trials
NCT07624409Early Phase 1
Program Protocol for a Population That Works in Conditions of Hypobaric Hypoxia
NCT06299878
MelPRO-0322 (CRISTINA Trial) [miCrobiome pRedIctS aPD1 effecTivnes In melaNoma pAtietns]
NCT05628493
Gut Microbiota Analysis in IAI Patients With Sepsis-associated Liver Dysfunction
All 3 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 3